GAINERS
COMPANY SYMBOL LAST CHANGE PERCENT VOLUME
------- ------ ---- ------ ------- ------
Capricor Therapeutics CAPR 6.65 2.44 57.96 65,863,688
Harte-Hanks HHS 4.30 1.49 53.02 4,643,330
Eton Pharmaceuticals ETON 58.86 18.06 44.26 2,291,527
Digital Asset Acqn Cl A DAAQ 10.42 3.16 43.53 114,642
Heartflow HTFL 42.08 11.07 35.70 9,898,070
Apollomics Cl A APLM 23.40 6.03 34.72 47,621
Evolution Metals & Techs EMAT 3.03 0.77 34.07 3,511,328
NeOnc Technologies Hldgs NTHI 4.22 1.01 31.46 639,874
Valneva ADR VALN 7.13 1.48 26.19 2,869,976
GrShr 2x Long RDDT Daily RDTL 18.69 3.71 24.77 1,914,641
LOSERS
COMPANY SYMBOL LAST CHANGE PERCENT VOLUME
------- ------ ---- ------ ------- ------
Innventure INV 1.62 -1.99 -55.14 32,256,347
YXT.COM Group Holding ADR YXT 3.57 -2.08 -36.81 449,130
Dawson Geophysical DWSN 3.20 -1.37 -29.93 516,695
Intellicheck IDN 2.81 -0.95 -25.20 2,577,666
Leverage 2X Lg BLSH Dly BLSG 1.69 -0.50 -23.05 126,194
Leverage 2X Lg GEMI Dly GEMG 6.60 -1.37 -17.21 26,137
Leverage 2X Lg DUOL Dly DUOG 47.68 -8.94 -15.80 9,969
Merlin MRLN 3.76 -0.67 -15.05 2,210,094
Anbio Biotechnology NNNN 8.74 -1.52 -14.81 71,732
Zentalis Pharmaceuticals ZNTL 3.56 -0.59 -14.22 4,575,241
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments